Farhoumand, L.S.; Fiorentzis, M.; Kraemer, M.M.; Sak, A.; Stuschke, M.; Rassaf, T.; Hendgen-Cotta, U.; Bechrakis, N.E.; Berchner-Pfannschmidt, U.
The Adrenergic Receptor Antagonist Carvedilol Elicits Anti-Tumor Responses in Uveal Melanoma 3D Tumor Spheroids and May Serve as Co-Adjuvant Therapy with Radiation. Cancers 2022, 14, 3097.
https://doi.org/10.3390/cancers14133097
AMA Style
Farhoumand LS, Fiorentzis M, Kraemer MM, Sak A, Stuschke M, Rassaf T, Hendgen-Cotta U, Bechrakis NE, Berchner-Pfannschmidt U.
The Adrenergic Receptor Antagonist Carvedilol Elicits Anti-Tumor Responses in Uveal Melanoma 3D Tumor Spheroids and May Serve as Co-Adjuvant Therapy with Radiation. Cancers. 2022; 14(13):3097.
https://doi.org/10.3390/cancers14133097
Chicago/Turabian Style
Farhoumand, Lina S., Miltiadis Fiorentzis, Miriam M. Kraemer, Ali Sak, Martin Stuschke, Tienush Rassaf, Ulrike Hendgen-Cotta, Nikolaos E. Bechrakis, and Utta Berchner-Pfannschmidt.
2022. "The Adrenergic Receptor Antagonist Carvedilol Elicits Anti-Tumor Responses in Uveal Melanoma 3D Tumor Spheroids and May Serve as Co-Adjuvant Therapy with Radiation" Cancers 14, no. 13: 3097.
https://doi.org/10.3390/cancers14133097
APA Style
Farhoumand, L. S., Fiorentzis, M., Kraemer, M. M., Sak, A., Stuschke, M., Rassaf, T., Hendgen-Cotta, U., Bechrakis, N. E., & Berchner-Pfannschmidt, U.
(2022). The Adrenergic Receptor Antagonist Carvedilol Elicits Anti-Tumor Responses in Uveal Melanoma 3D Tumor Spheroids and May Serve as Co-Adjuvant Therapy with Radiation. Cancers, 14(13), 3097.
https://doi.org/10.3390/cancers14133097
